0
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

The profile of soluble adhesion molecules in patients with Behcet's disease: a possible association with disease activity

Pages 203-209 | Published online: 05 Sep 2013

References

  • Kishimoto YK, Larson RS, Corbi AL, et al., The leukocyte integrins: LFA-1, Mac-1 and p150.95. Adv Immunol 46, 149–82(1989).
  • Gearing AJH, Newman W, Circulating adhesion molecules in disease. Immunol Today 14, 506–12 (1993).
  • Newman W, Beall LD, Carson CW, et al., Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150, 644–54 (1993).
  • Schleiffebaum BO, Spertini O, Tedder TF, Soluble L select in is present in human plasma at high levels and retains functional activity. J Cell Biol 119, 229–38 (1992).
  • Dunlop LC, Skinner MP, Bendall U, et al., Characterization of GMP-140 (p-selectin) as a circulating plasma protein. J Exp Med 175, 1147–50 (1992).
  • Goldberger A, Middlelaton KA, Oliver JA, et al., Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 269, 17183–91 (1994).
  • Wellicome SM, Kapahi P, Mason JC, et al., Detection of a circulating form of vascular cell adhesion molecule-1: paired levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 92, 412–18 (1993).
  • Seth R, Raymond FD, Makgoba MW, Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 33, 83–4 (1991).
  • Buckle AM, Hogg N, Human memory T cells: express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-y. Eur J Immunol 20, 337–41 (1990).
  • Dustin ML, Rothlein R, Bhan AK, et al., Induction by 1L-1 and interferon-y: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137, 245–54 (1986).
  • Tedder TF, Penta AC, Levine HB, et al., Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQl and Leu- 8 differentiation antigens. J Immunol 144, 532–40 (1990).
  • Springer TA, Adhesion receptors of the immune system. Nature 346, 425–34 (1990).
  • Janssen BA, Lugmani RA, Gordon C, et al., Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 33, 1112–6 (1994).
  • Stegeman CA, Tervaert JWC, Huitema MG, et al., Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selec tin in patients with Wegener granulomatosis. Arthritis Rheum 37, 1228–35 (1994).
  • Mrowka C, Sieberth HG, Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Invest 72, 762–8 (1994).
  • Oppenimer-Marks, Lipsky PE, Adhesion molecules as targets for the treatment of autoimmune diseases. Clin Immunol Immunopathol 79, 203–10 (1996).
  • Yazici H, Yurdakul S, Hamuryudan V, Behcet's Syndrome. In: Klippel JH, Dieppe PA (Eds), Rheumatology, Second Edition. Mosby (1998).
  • International Study Group of Behcet's Disease, Criteria for diagnosis of Behcet's disease. Lancet 335, 1078–80 (1990).
  • Littler AJ, Buckley CD, Wordsworth P, et al., A distinct profile of six soluble adhesion molecules in rheumatoid arthritis. Br J Rheumatol 36, 164–9 (1997).
  • Coll-Vinent B, Grau JM, Lopez-Soto A, et al., Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 36, 1178–83 (1997).
  • Coll-Vinent B, Vilardell C, Font C, et al., Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (SICAM-1) concentrations and disease activity. Ann Rheum Dis 58, 189–92 (1999).
  • Uchio E, Matsumoto T, Tanaka SI, et al., Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behcet's disease and Vogt—Koyanagi—Harada's disease. Clin Exp Rheumatol 17(2), 179–84 (1999).
  • Tugal-Tutkun I, Urgancioklu M, Foster CS, Immunopathologic study of the conjuctiva in patients with Behcet disease. Ophthalmology 102(11), 1660–8 (1995).
  • Verity DH, Wallace GR, Seed PT, et al., Soluble adhesion molecules in Behcet's disease. Ocul Immunol Inflamm 6(2), 81–92 (1998).
  • Aydintug AO, Tokgoz G, Ozoran K, et al., Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behcet's disease. Rheumatol Int 15(2), 75–8 (1995).
  • Pall AA, Adu D, Drayson M, et al., Circulating soluble adhesion molecules in systemic vasculitis. Nephrol Dial Transplant 9, 770–4 (1994).
  • Gordon M, Luqmani RA, Adu D et al., Relapses in patients with a systemic vasculitis. Quart J Med 86, 779–89 (1993).
  • McEver RP, Selectins. Curr Opin Immunol 6, 75–84 (1994).
  • Wellicome SM, Kapahi P, Mason JC, et al., Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 92, 412–8 (1993).
  • Cush JJ, Rothlein R, Lindsley HB, et al., Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 36, 1098–102 (1993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.